Health
Researchers develop α-emitting cancer therapy using a novel drug targeting LAT1 – News-Medical.Net
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues.
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.
The researchers first produced the alpha-ray emitter 211Astatine, no easy task given that Astatine…
-
General21 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
Business16 hours agoWhat it means for shareholders
-
Business19 hours agoUp 48% in a month, can Domino’s Pizza shares keep the momentum going?
-
Noosa News18 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months